Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a Murine model of allergic asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 4, 1998, Pages 622-628

  Van Oosterhout, Antoon J M ^a   Van Esch, Betty ^b   Hofman, Gerard ^b   Hofstra, Claudia L ^b   Van Ingrid, Ark ^b   Nijkamp, Frans P ^b   Kapsenberg, Martien L ^b   Savelkoul, Huub F J ^b   Weller, Frank R ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOCONSTRICTING AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; METHACHOLINE CHLORIDE; OVALBUMIN;

ALLERGIC PNEUMONITIS; ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DESENSITIZATION; DISEASE MODEL; GERMFREE ANIMAL; IMMUNOLOGY; INHALATION TEST; LOEFFLER PNEUMONIA; LUNG LAVAGE; LYMPH NODE; MALE; METABOLISM; MOUSE; T LYMPHOCYTE;

ALVEOLITIS, EXTRINSIC ALLERGIC; ANIMALS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTOR AGENTS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LYMPH NODES; MALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY EOSINOPHILIA; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES;

EID: 0032185775     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.4.3112m     Document Type: Article

References (26)

1. Noon, L., and B. C. Cantab. 1911. Prophylactic inoculation against hay fever. Lancet 1:1572-1574.
2. Abramson, M. J., R. M. Puy, and J. M. Weiner. 1995. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am. J. Respir. Crit. Care Med. 151:969-974.
3. Bousquet, J., and F. B. Michel. 1994. Specific immunotherapy in asthma: is it effective? J. Allergy Clin. Immunol. 94:1-11.
4. Creticos, P. S., C. E. Reed, V. S. Norman, J. Khoury, N. V. Adkinson, Jr., C. R. Buncher, W. W. Busse, R. K. Bush, J. Gadde, J. T. Li, H. B. Richerson, R. R. Rosenthal, W. R. Solomon, P. Steinberg, and J. W. Yunginger. 1996. Ragweed immunotherapy in adult asthma. N. Engl. J. Med. 334:501-506.
5. McHugh, S. 1996. Immunological responses to immunotherapy. Clin. Exp. Allergy 26:1101-1104.
6. + T-cells from allergic individuals. J. Exp. Med. 178:2123-2130.
7. Hessel, H. M., A. J. M. Van Oosterhout, C. L. Hofstra, J. J. De Bie, J. Garssen, H. Van Loveren, A. K. C. P. Verheyen, H. F. J. Savelkoul, and F. P. Nijkamp. 1995. Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. 293:401-412.
8. Hessel, E. M., A. J. M. Van Oosterhout, C. L. Hofstra, J. Garssen, H. Van Loveren, H. F. J. Savelkoul, and F. P. Nijkamp. 1994. Repeated ovalbumin inhalation causes bronchial hyperresponsiveness and eosinophil infiltration in sensitized mice. Am. Rev. Respir. Dis. 149:A754. (Abstr.)
9. Hessel, E. M., A. J. M. Van Oosterhout, I. Van Ark, U. Van Esch, G. Hofman, H. Van Loveren, H. F. J. Savelkoul, and F. P. Nijkamp. 1997. Development of airway hyperresponsiveness is dependent of IFN-γ and independent of eosinophil infiltration. Am. J. Resper. Cell Mol. Biol. 16:325-335.
10. De Bie, J. J., E. M. Hessel, I. Van Ark, B. Van Esch, G. Hofman, F. P. Nijkamp, and A. J. M. Van Oosterhout. 1996. Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br. J. Pharmacol. 119:1484-1490.
11. Van Halteren, A. G. S., M. J. F. Van Der Cammen, J. Biewenga, H. F. J. Savelkoul, and G. Kraal. 1997. IgE and mast cell responses on intestinal allergen exposure: a murine model to study the onset of food allergy. J. Allergy Clin. Immunol. 99:94-99.
12. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
13. Vossen, A. C., G. J. Tibbe, M. J. Kroos, J. G. Van De Winkel, R. Benner, and H. F. Savelkoul. 1995. Fe receptor binding of anti-CD3 monoclonal antibodies is not essential lor immunosuppression, but triggers cytokine-related side effects. Eur. J. Immunol. 25:1492-1496.
14. Lichtenstein, L. M., K. Ishizaka, P. S. Norman, A. K. Sobotka, and B. M. Hill. 1973. IgE antibody measurements in ragweed hayfever. Relationship to clinical severity and the results of immunotherapy. J. Clin. Invest. 52: 472-482.
15. Golden, D. B. K., D. A. Meyers, A. Kagey-Sobotka, M. D. Valentine, and L. M. Lichtenstein. 1982. Clinical relevance of venom-specific immunoglobulin G antibody level during immunotherapy. J. Allergy Clin. Immunol. 69:489-193.
16. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
17. McHugh, S. M., J. Deighton, A. G. Stewart, P. J. Lachman, and P. W. Ewan. 1995. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional therapy. Clin. Exp. Allergy 25:828-838.
18. Rocklin, R. E., A. L. Sheffer, D. R. Greineder, and K. L. Melmon. 1980. Generation of antigen-specific suppressor cells during allergy desensitization. N. Engl. J. Med. 302:1213-1219.
19. Durham, S. R., S. Ying, V. A. Varney, M. R. Jacobson, R. M. Sudderick, I. S. Mackay, A. B. Kay, and Q. A. Hamid. 1996. Grass pollen immunotherapy inhibits allergen-induced infiltration of cells expressing messenger RNA for interferon-γ. J. Allergy Clin. Immunol. 97:1356-1365.
20. Renz, H., G. Lack, J. Saloga, R. Schwinzer, K. Bradley, J. Loader, A. Kupfer, G. L. Larsen, and E. W. Gelfand. 1994. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J. Immunol. 152:351-360.
21. Hofstra, C. L., I. Van Ark, G. Hofman, P. M. Jardieu, F. P. Nijkamp, and A. J. M. Van Oosterhout. 1996. Differential effects of endogenous and exogenous IFN-γ on IgE, cellular infiltration, and airway responsiveness in a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. (In press)
22. Lack, G., K. L. Bradley, E. Hamelman, H. Renz, J. Loader, D. Y. M. Leung, G. Larsen, and E. W. Gelfand. 1996. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J. Immunol. 157:1432-1439.
23. + T cells. J. Exp. Med. 177:573-576.
24. Nicklas, R. A., I. F. Bernstein, J. Blessing-Moore, S. M. Fineman, A. A. Gutman, R. E. Fee, J. T. Li, W. E. Berger, and S. L. Spector. 1996. Practice parameters for allergen immunotherapy. J. Allergy Clin. Immunol. 6:1001-1011.
25. Boulet, L. P., K. R. Chapman, J. Cote, S. Kalra. R. Bhagat, V. A. Swystun, M. Laviolette, L. D. Cleland, F. Deschesnes, J. Q. Su, A. Devault, R. B. Fick, and D. W. Cockcroft. 1997. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am. J. Respir. Crit. Care Med. 155:1835-1840.
26. Takai, T., T. Yokota, M. Yasue, C. Nishiyama, I. Yuuki, A. Mori, H. Okudaira, and Y. Okumura. 1997. Engineering of the major house dust mite allergen Der f2 for allergen-specific immunotherapy. Nature Biotechnol. 15: 754-758.